Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133581) titled 'Remote, Continuous, Non-Invasive Monitoring and Diagnosis of Renal Function Using a Novel Wearable NH3 Sensor' on Sept. 29.
Study Type: Diagnostic test
Study Design:
Sequential
Primary Sponsor: Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Condition:
N/A
Intervention:
Gold Standard:Use blood creatinine as the gold standard for diagnosis, and glomerular filtration rate as the staging diagnostic criterion.
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2025-06-07
Target Sample Size: Target condition:395;Difficult condition:0
Countries of Recru...